NDC 69097-950 - LEUPROLIDE ACETATE DEPOT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69097-950
- Package NDCs from labels
- 69097-950-32
- Manufacturer
- CIPLA USA INC. | GP PHARM SA
- Effective date
- 2024-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEUPROLIDE ACETATE DEPOT - CIPLA USA INC. | GP PHARM SA | CIPLA USA INC. | GP PHARM SA | 2024-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69097-950-32 | LEUPROLIDE ACETATE DEPOT | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 2 mL | 22.5 mg in 2mL | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Household Detox | PTELEA TRIFOLIATA, ALLIUM SATIVUM, PETROLEUM, CARBONEUM SULPHURATUM, ALUMINA, BENZINUM, BISPHENOL A, CARBOLICUM ACIDUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PARAFFINUM, PHENACETINUM, SODIUM CARBOXYMETHYL CELLULOSE, FOLLICULINUM, ANTIPYRINUM, DIOXIN, DIETHYLSTILBESTROL, TEFLON | Deseret Biologicals, Inc. | 7e32c1f4-c88e-43d0-9f6c-de736d358d46 | 2024-09-27 | Warnings | K679OBS311 |
| LEUPROLIDE ACETATE DEPOT | LEUPROLIDE ACETATE | CIPLA USA INC. | 1563a30b-66e0-445d-ba3e-1ccd5218133f | 2024-08-27 | Warnings, Adverse reactions | NDA205054 69097-960-31 69097-950-32 69097-909-50 69097-909 2606516 15d87847-b4c3-48bc-8c40-d8fc63fcb1b0 1563a30b-66e0-445d-ba3e-1ccd5218133f |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Endo USA, Inc. | 290b0716-2fd5-43a1-8d3c-4857c1b2eefa | 2024-06-10 | Warnings, Adverse reactions | 37JNS02E7V |
| Eyes Alive Lubricating | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | RIVIERA PHARMA INC | b6966691-6884-438c-9f89-5924089226e1 | 2024-05-31 | Warnings | K679OBS311 |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| Equate Lubricant Eye Drops Preservative-Free | CARBOXYMETHYLCELLULOSE SODIUM | Wal-Mart Stores, Inc. | 9228a39b-38d2-1dfc-e053-2a95a90a3c90 | 2023-12-23 | Warnings | K679OBS311 |
| Equate Restore Plus Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Walmart, Inc. | 9e665ca2-4fa6-fdb4-e053-2a95a90abcca | 2023-12-23 | Warnings | K679OBS311 |
| Leader Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Cardinal Health | 8d9a4eec-bf0e-6c3b-e053-2995a90ae9aa | 2023-12-23 | Warnings | K679OBS311 |
| Good Neighbor Pharmacy Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Amerisource Bergen Drug Corp. | fd2dc23f-6ccc-2644-e053-6294a90a889e | 2023-12-23 | Warnings | K679OBS311 |
| Walgreens Lubricant Eye Drops Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM | Walgreen Company | 9912b773-e7a5-3a82-e053-2995a90a5b2c | 2023-12-20 | Warnings | K679OBS311 |
| Lubricant Eye Drops Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM | Target Corporation | 454ce049-49e5-48b1-8499-048e5e7d72d3 | 2023-12-20 | Warnings | K679OBS311 |
| Rugby Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Rugby Laboratories | f9292d5d-e0a3-9287-e053-6294a90a43e9 | 2023-12-20 | Warnings | K679OBS311 |
| Signature Care Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Better Living Brands LLC | ea358e01-f03e-454b-bae1-6c83da44c369 | 2023-12-20 | Warnings | K679OBS311 |
| Kroger Lubricant Eye | CARBOXYMETHYLCELLULOSE SODIUM | The Kroger Co. | 046f4ebc-d8f9-4755-b6ba-790fe86f3128 | 2023-12-20 | Warnings | K679OBS311 |
| HEB Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | HEB | 5d522e4d-d647-486f-a947-25c14b1417fa | 2023-12-20 | Warnings | K679OBS311 |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H K679OBS311 |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H K679OBS311 |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | K679OBS311 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.